Provide the indicated post anesthesia care. If one or more of the above services are not performed by the anesthesiologist, the service is not considered medical direction. Ordinarily, anesthesiologist should not furnish additional services to other patients while concurrently directing the administration of anesthesia.
a fixed-dose combination of ledipasvir, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir, an HCV nucleotide analog NS5B polymerase inhibitor, and is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.
TREATMENT SIDE EFFECT MANAGEMENT. 1. June 2014: Hepatitis C (HCV) treatment has dramatically improved with the introduction. of direct-acting antivirals (DAAs). Current treatment for chronic hepatitis C virus infection. (HCV) can cure up to 95% of patients who undergo antiviral therapy. However, HCV medica-. tions have troublesome side effects, which can lead to dose reduction or discontinuation of. therapy.